The three types of skin cancer are basal cell carcinoma, squamous cell carcinoma, and melanoma. Here's how to identify their subtly different signs.
Libtayo gained FDA approval as the first immunotherapy for high-risk cutaneous squamous cell carcinoma, promising improved outcomes post-surgery and radiation.
The decision follows phase 3 trial data showing the immunotherapy cut disease recurrence or death risk by 68% in patients ...
On October 8, 2025, the US FDA approved the immunotherapy cemiplimab-rwlc (Libtayo) for adjuvant treatment of adult patients ...
Skin malignancies are the most common cancers in the United States. 1 Typically, skin cancer is categorized as either melanoma or nonmelanoma skin cancer, which is also known as keratinocyte ...
Camrelizumab/famitinib combination significantly improved PFS and OS over platinum-based chemotherapy in recurrent/metastatic ...
In the U.S., the generic name for Libtayo in its approved indications is cemiplimab-rwlc, with rwlc as the suffix designated in accordance with Nonproprietary Naming of Biological Products Guidance ...
WASHINGTON -- President Joe Biden's doctor said Friday that a lesion removed from the president's chest last month was basal cell carcinoma, a common type of skin cancer. Dr. Kevin O'Connor wrote in a ...
Q. I am in my 60s and live in Australia. For the past 20 years, I’ve had numerous basal and squamous cell skin cancers removed. Every six months, I’d have to get another check and get something ...
The first reported cases of PKMB appeared in the French literature in the 1960s (Lortat-Jacob & Civatte, 1961). They described a lesion of the glans penis characterized by thick, hyperkeratotic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback